Volume 13, Issue 41 (Dec 2003)                   J Mazandaran Univ Med Sci 2003, 13(41): 32-40 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zareh M, Saadetnia M, Haghighi S. Antiphospholipid antibody in stroke in young adults: A study on 23 patients with titer higher than normal in Isfahan . J Mazandaran Univ Med Sci 2003; 13 (41) :32-40
URL: http://jmums.mazums.ac.ir/article-1-348-en.html
Abstract:   (13570 Views)
Background and purpose: Ôf the agents involved in stroke, is presence of antiphospholipid antibody in serum of the patients. Ïn recent years, in addition to cardiolipin antibody (aÇL) another antiphospholipid antibody (aPL) was identified as the predispousing factor of stroke. Ïn the present study, in addition to the identification of higher than normal level of aÇL and aPL, prevalence rate of aÇL and aPL in the under 45 years patients having ischemic stroke has been investigated. '
Materials and methods : Ïn a descriptive study done in 45 years ischemic stroke patients referring to Ïsfahan Âlzahrah hospitals, the aÇL and aPL (ÏgM,ÏgG) titers were measured, then clinical, laboratory and demographic titers higher than normal were studied.
Results : Ôf 114 patients, 23 (19.5%) had ÏgM and ÏgG titers of acL and apL higher than normal. Ôf these 18(15.3%) patients with aÇL titer higher than normal, 7 were men and 16 women. Higher than normal of aÇL of type ÏgM and ÏgG were in 15(65.2%) and 8(34.7%) respectively and aPL of type ÏgM and ÏgG were in 19(82.6%) and 6(26%) respectively. Ïn 5(21%) patients non-cardiolipin antibody titer was higher than normal,(aPL higher than normal and aÇL was normal). Ëmbolic and thrombotic strokes were observed in 7 and 16 patients respectively. History of previous stroke was seen in 7 patients. Heart. Valvolar involevement was detected in 47% of the patients.
Discussion: The results show that majoritiy of the under 45 years patients with ischemic stroke in Ïran have the antiphospholipid antibody titer higher than normal range and approximately 20% of the patients have non anti cardiolipin antibody higher than normal. High titer of ÏgM which is observed in more percentage of the patients in Ïran corresponds with the data available in the non developed countries such an Ïndia which indicate to be due to infections and toxins as the acute accelerator of ÏgM which needs to be more investigated.
Full-Text [PDF 163 kb]   (2028 Downloads)    
Type of Study: Research(Original) |

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb